Patents Represented by Attorney Stephen Gates
  • Patent number: 5482848
    Abstract: An 80 kDa metaloproteinase is found in hormone-dependent human breast cancer cells. The enzyme is active in the presence of calcium, manganese, or magnesium ions. The 80 kDa proteinase is useful for evaluating therapeutic progress and in formulating plans for treatment.
    Type: Grant
    Filed: February 22, 1994
    Date of Patent: January 9, 1996
    Assignee: Georgetown University
    Inventors: Robert B. Dickson, Yuenian E. Shi
  • Patent number: 5478374
    Abstract: The nitrogen in amides of aldonic and aldaric acids having 5 or 6 carbon atoms in the carbohydrate residue is available to support plant growth, i.e. the materials act as nitrogen fertilizers.
    Type: Grant
    Filed: June 3, 1994
    Date of Patent: December 26, 1995
    Inventor: Donald E. Kiely
  • Patent number: 5478566
    Abstract: 3.beta.,7.beta.,17.beta.-androstenetriol (".beta.AET") may be used to increase production of IL-2 in cell culture and in the intact animal. Increase in IL-2 under stimulating effect of .beta.AET provides benefits associated with IL-2 administration without the untoward effects such as increased cortisol production.
    Type: Grant
    Filed: September 29, 1993
    Date of Patent: December 26, 1995
    Inventor: Roger M. Loria
  • Patent number: 5473035
    Abstract: Novel monomers are described which contain a glucaric acid unit linked through an amide bond formed between a carbonyl carbon of a D-glucaric acid and one of the amino nitrogens of a primary diamine as well as their alkali metal salts. These N-aminohydrocarbylene (or N-aminoheterohydrocarbylene)-D-glucaramidates may then be polymerized to form polyhydroxypolyamides and in particular stereoregular polyhydroxypolyamides.
    Type: Grant
    Filed: April 11, 1994
    Date of Patent: December 5, 1995
    Inventors: Donald E. Kiely, Liang Chen
  • Patent number: 5466153
    Abstract: The invention is a device for use as a prop to hold the mouth open which consists essentially of a bite block with an elongated portion that is deflected to provide a turn of about 180.degree. so that the elongated portion extends around the outside of the cheek with the end of the extension pointing backward from the mouth to form a handle by which the bite block is held in position.
    Type: Grant
    Filed: March 16, 1994
    Date of Patent: November 14, 1995
    Inventor: Forrest R. Poindexter
  • Patent number: 5464018
    Abstract: A method of evaluating salt sensitivity in a hypertensive patient comprises evaluating customary salt intake and deleting from the diet any substance other than salt that might influence blood pressure, feeding the patient a diet without restriction of salt and measuring blood pressure until blood pressure becomes stabilized at the hypertensive level or, if hypertension is not seen, for about 90 days, thereafter restricting the salt intake in the diet, and gradually increasing the salt intake and measuring blood pressure to determine when the blood pressure begins to rise during the period of increasing salt intake to determine salt sensitivity that gives rise to hypertension.
    Type: Grant
    Filed: December 19, 1994
    Date of Patent: November 7, 1995
    Inventor: Carlos H. Espinel
  • Patent number: 5461042
    Abstract: The present invention provides an improved compositions and methods for regulating the immune response, for ameliorating effects of stress, and for avoiding untoward effects of chemotherapy or exposure to irradiation by administration of androstenediol (AED) and androstenetriol (AET). The improved means of regulating immune response can be utilized in treating infectious diseases and immune diseases such as diabetes and chronic fatigue syndrome, both diseases now considered to be immune response related syndromes.
    Type: Grant
    Filed: January 3, 1994
    Date of Patent: October 24, 1995
    Inventor: Roger M. Loria
  • Patent number: 5452487
    Abstract: An inflatable enclosure useful as a matress is described which has first (bottom) and second (top) broad surfaces connected at their edges to form the enclosure, the bottom being formed of a substantially air-impermeable resilient closed-cell foam wherein the thickness and density of the closed-cell foam has been selected to provide semi-rigid characteristics between adjacent points of support and the top being formed of material selected from an air-impermeable resilient closed-cell foam and a flexible air-impervious material, said first surface being connected around its edges to a flexible air-impervious material which is in turn attached around the edges of the second surface to form the enclosure, the enclosure having at least one closable means for admitting a fluid to and releasing fluid from the enclosure.
    Type: Grant
    Filed: July 18, 1994
    Date of Patent: September 26, 1995
    Inventor: Dennis V. Leggett
  • Patent number: 5434233
    Abstract: Polymers of glucaric or xylaric acid with diprimary amines containing at least one heteroatom in the main chain form films when cast from aqueous solution and show adhesive properties. Unexpectedly, analogous polymers prepared using galactaric acid, an isomer of glucaric acid, do not form satisfactory films when cast from aqueous solution and exhibit poor or no adhesive properties. Copoly(aldaramides) comprising galactaric acid residues and either glucaric acid or xylaric acid residues, when prepared by reacting an equivalent weight of an activated galactarate with a product formed by reaction of two equivalents of a diprimary heterohydrocarbylenediamine with one equivalent of either an activated xylarate or glucarate also afford film-forming polymers which exhibit adhesive properties.
    Type: Grant
    Filed: May 24, 1994
    Date of Patent: July 18, 1995
    Inventors: Donald E. Kiely, Liang Chen, David W. Morton
  • Patent number: 5431881
    Abstract: A kit for use in determining the dosages and administering testosterone for the treatment of hair loss and disorders involving the lubricating function of the skin.
    Type: Grant
    Filed: December 10, 1993
    Date of Patent: July 11, 1995
    Inventor: Henry J. Palacios
  • Patent number: 5424141
    Abstract: Processes for transfer of design and kite therefore are easily used to transfer images on objects, including fine materials such as silk. The recipient materials remain pliable. Kits containing components for use in the processes of the invention may be prepared for use with any transfer materials. Fabric that has been decorated by the processes of the invention can be sewed, washed, and dried without releasing the image transferred thereto.
    Type: Grant
    Filed: July 27, 1992
    Date of Patent: June 13, 1995
    Inventor: Marjorie Croner
  • Patent number: 5409908
    Abstract: This invention relates to use of cyclodextrins to complex urushiols to protect against and to treat irritation arising from exposure to urushiols. Cyclodextrins, particularly gamma-cyclodextrins, are capable of binding strongly to urushiols and can be used effectively to prevent irritation of tissue that is exposed to urushiols.Cyclodextrin-urushiol complexes can also be used to desensitize against urushiol. Compositions containing cyclodextrin/urushiol complexes may be provided as tablets for buccal administration in dosages sufficient to induce desensitizing response.
    Type: Grant
    Filed: October 20, 1993
    Date of Patent: April 25, 1995
    Assignee: Vyrex Corporation
    Inventors: Robert A. Sanchez, Sheldon S. Hendler
  • Patent number: 5407663
    Abstract: Patients may effectively be treated for inflammatory conditions of the mouth using aqueous anti-inflammatory steroids in solutions that can be swished and expectorated as a mouthwash. Such therapy would allow direct contact of the medication with the diseased mucous membranes and would contact areas of the oral cavity that would not usually be reached with application of creams, gels, or ointments. Compositions containing antifungal agents in addition to steroids are particularly useful.Swishing for three to five minutes, then expectorating the aqueous anti-inflammatory-containing, results in maintenance of contact of the active agents with the oral cavity surfaces for a longer time than would application of gels containing those agents. The mode of application is simple and is not repugnant to the patient as is the application of creams, gels, or ointments.
    Type: Grant
    Filed: April 4, 1994
    Date of Patent: April 18, 1995
    Inventor: Drore Eisen
  • Patent number: 5387583
    Abstract: 3.beta.,17.beta.-androstenediol (".beta.AED") and 3.beta.,7.beta.,17.beta.-androstenetriol (".beta.AET") may be used to counteract the antiproliferative and immunosuppressive effects of hydrocortisone and other corticosteroids (i.e., to act as buffers to counteract the lymphosuppressive response to such steroids). .beta.AED and .beta.AET are steroids which mediate immune response to provide the body protection against immune down-regulation. A method for testing analogues of .beta.AED and .beta.AET to compare the effectiveness of such analogues as buffers of certain effects of hydrocortisone and other corticosteroids, including immune response and proliferative effects is described. Cytokines, including most particularly IL-3, are produced by addition of .beta.AET and .beta.AED and their analogues to the growth media of cell cultures of lymphatic cells.
    Type: Grant
    Filed: April 20, 1993
    Date of Patent: February 7, 1995
    Inventor: Roger M. Loria
  • Patent number: 5380711
    Abstract: The present invention provides delipidating compositions containing essentially oil-free "empty" cyclodextrin compositions. It also provides compositions for use in removal of cerumen from the ear. The compositions containing "empty" cyclodextrin advantageously avoid use of harsh, drying agents or injurious mechanical methods.
    Type: Grant
    Filed: March 15, 1994
    Date of Patent: January 10, 1995
    Assignee: Vyrex Corporation
    Inventors: Robert A. Sanchez, Sheldon S. Hendler
  • Patent number: 5329656
    Abstract: A mattress is disclosed which eliminates components by combining structural integrity, air-impervious and insulating functions, thereby significantly reducing overall weight and increasing portability. In a particularly preferred embodiment the mattress is self-inflating. The semi-rigid cover provides the dimensional rigidity necessary to effect self-inflation. The increased thickness of the utilized cover component affords improved puncture resistance.
    Type: Grant
    Filed: December 3, 1992
    Date of Patent: July 19, 1994
    Assignee: Dennis V. Leggett
    Inventor: Dennis V. Leggett
  • Patent number: 5329044
    Abstract: Novel monomers are described which contain a glucaric acid unit linked through an amide bond formed between a carbonyl carbon of a D-glucaric acid and one of the amino nitrogens of a primary diamine as well as their alkali metal salts. These N-aminohydrocarbylene (or N-aminoheterohydrocarbylene)-D-glucaramidates may then be polymerized to form polyhydroxypolyamides and in particular stereoregular polyhydroxypolyamides.
    Type: Grant
    Filed: August 12, 1992
    Date of Patent: July 12, 1994
    Inventors: Donald E. Kiely, Liang Chen
  • Patent number: 5312967
    Abstract: A single step process for converting aldaric acid salts to activated aldarates utilizing a lower alkanol as both solvent and esterifying agent is described. The activated aldarates are particularly useful as monomers for polymerizations with primary diamines in which the nitrogen atoms are bound to aliphatic carbon atoms to form poly(aldaramides).
    Type: Grant
    Filed: August 12, 1992
    Date of Patent: May 17, 1994
    Assignee: UAB Research Foundation
    Inventors: Donald E. Kiely, Liang Chen, David W. Morton
  • Patent number: 5310545
    Abstract: Compositions used to treat inflammatory diseases of the mouth contain anti-inflammatory steroids in combination with antifungal drugs in an aqueous medium as a mouthwash. Swishing for three to five minutes, then expectorating the mouthwashes results in maintenance of contact of the active agents with the oral cavity surfaces for a longer time than would application of gels containing those agents. The mode of application is simple and is not repugnant to the patient as is the application of creams, gels, or ointments.
    Type: Grant
    Filed: January 15, 1993
    Date of Patent: May 10, 1994
    Inventor: Drore Eisen
  • Patent number: 5296472
    Abstract: This invention relates to methods for delipidation of skin or hair through the use of cyclodextrins and cyclodextrin derivatives such as hydroxypropyl .beta.-cyclodextrin. The invention also relates to cerumen removal methods involving introduction of cyclodextrins to the ear canal, followed by complexation of the cyclodextrin with cerumen components, and removal of the resulting cyclodextrin complexes. The cyclodextrin components are used in a substantially oil-free powdered or aqueous formulation without detergents, soaps, solvents, oils or other lipid-like agents.
    Type: Grant
    Filed: March 30, 1993
    Date of Patent: March 22, 1994
    Assignee: Vyrex Corporation
    Inventors: Robert A. Sanchez, Sheldon S. Hendler